2Scarliotti G V, De Marinis F, Rinaldi M, et al. Phase Ⅲ randomized trial comparing three platintrm-based doublets in advanced non-small-cell lung cancer[J]. J Clin Oncol, 2002,20(21):4285.
3Chevalier T L, Brisgand D, Dourllard J Y M, et al. Randomized study of vinorebline and cisplatin versus vindesine and cisplatin versus vinorebline alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients[J]. Clin Oncol, 1994, 12 (2): 360.
4Shephered F A. Chemotherapy for non-smalleell lung cancer have we reached a new plateau[J]. Semin Oncol, 1999, 26(Suppl4) : 3.
5Frances A. Chemotherapy for non-srnall-eell lung cancer:have we reached a new plateau[J]. Semin Oneol, 1999, 26(1): 3.
6Paul A, Bun J, Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced nonsmall-cell lung cancer[J]. Semin Oncol, 1999, 26(1): 25.
8Comella P. Phase Ⅲ trial of cisplatinl gemeitabine with or without vinorelbine or paelitaxel in advanced non-srnall-cell-lungcancer[J]. Semin Oncol, 2001, 28(Supp17): 7.
9Natale R B. Gemcitabine and nonplatinum combinations in non-small cell lung cancer [ J ]. Oncology (Huntingt), 2001,15(Suppl6) : 18.
10Baron F, Gueva J, Grana B, et al. Gemcitabine plus vinorelbine for the treatment, of advanced non-small cell lung cancer[J]. EurJ Cancer, 2001, 37(11): 1381.
